Prot# MD1003CT2016-01MS-SPI2: Effect of MD1003 in Progressive Multiple Sclerosis: A Randomized Double Blind Placebo Controlled Study

Project: Research project

Project Details

StatusActive
Effective start/end date5/25/17 → 5/25/23

Funding

  • Parexel (Prot# MD1003CT2016-01MS-SPI2)
  • MedDay SA (Prot# MD1003CT2016-01MS-SPI2)
View all
View less